nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Macular oedema—Niacin—atherosclerosis	0.0387	0.0387	CcSEcCtD
Verteporfin—Prostatic disorder—Niacin—atherosclerosis	0.0222	0.0222	CcSEcCtD
Verteporfin—Raised liver function tests—Niacin—atherosclerosis	0.0205	0.0205	CcSEcCtD
Verteporfin—Raised liver function tests—Pravastatin—atherosclerosis	0.0201	0.0201	CcSEcCtD
Verteporfin—Myasthenia—Niacin—atherosclerosis	0.015	0.015	CcSEcCtD
Verteporfin—Cataract—Lovastatin—atherosclerosis	0.0116	0.0116	CcSEcCtD
Verteporfin—Musculoskeletal pain—Lovastatin—atherosclerosis	0.0111	0.0111	CcSEcCtD
Verteporfin—Inflammation—Ezetimibe—atherosclerosis	0.0111	0.0111	CcSEcCtD
Verteporfin—Sleep disorder—Rosuvastatin—atherosclerosis	0.0109	0.0109	CcSEcCtD
Verteporfin—Cataract—Simvastatin—atherosclerosis	0.0108	0.0108	CcSEcCtD
Verteporfin—Inflammation—Simvastatin—atherosclerosis	0.0106	0.0106	CcSEcCtD
Verteporfin—Cataract—Pravastatin—atherosclerosis	0.00977	0.00977	CcSEcCtD
Verteporfin—Hearing impaired—Pravastatin—atherosclerosis	0.00977	0.00977	CcSEcCtD
Verteporfin—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00941	0.00941	CcSEcCtD
Verteporfin—Photosensitivity—Lovastatin—atherosclerosis	0.00909	0.00909	CcSEcCtD
Verteporfin—Photosensitivity—Ezetimibe—atherosclerosis	0.00892	0.00892	CcSEcCtD
Verteporfin—Sleep disorder—Simvastatin—atherosclerosis	0.00863	0.00863	CcSEcCtD
Verteporfin—Photosensitivity—Simvastatin—atherosclerosis	0.0085	0.0085	CcSEcCtD
Verteporfin—Eczema—Simvastatin—atherosclerosis	0.00831	0.00831	CcSEcCtD
Verteporfin—Muscular weakness—Rosuvastatin—atherosclerosis	0.00831	0.00831	CcSEcCtD
Verteporfin—Influenza—Rosuvastatin—atherosclerosis	0.00814	0.00814	CcSEcCtD
Verteporfin—Atrial fibrillation—Simvastatin—atherosclerosis	0.00788	0.00788	CcSEcCtD
Verteporfin—Sleep disorder—Pravastatin—atherosclerosis	0.0078	0.0078	CcSEcCtD
Verteporfin—Photosensitivity—Pravastatin—atherosclerosis	0.00769	0.00769	CcSEcCtD
Verteporfin—Eczema—Niacin—atherosclerosis	0.00763	0.00763	CcSEcCtD
Verteporfin—Atrial fibrillation—Niacin—atherosclerosis	0.00724	0.00724	CcSEcCtD
Verteporfin—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00723	0.00723	CcSEcCtD
Verteporfin—Dermatitis bullous—Niacin—atherosclerosis	0.00717	0.00717	CcSEcCtD
Verteporfin—Muscular weakness—Ezetimibe—atherosclerosis	0.00691	0.00691	CcSEcCtD
Verteporfin—Influenza—Lovastatin—atherosclerosis	0.0069	0.0069	CcSEcCtD
Verteporfin—Influenza—Ezetimibe—atherosclerosis	0.00677	0.00677	CcSEcCtD
Verteporfin—Diplopia—Pravastatin—atherosclerosis	0.00675	0.00675	CcSEcCtD
Verteporfin—Muscular weakness—Simvastatin—atherosclerosis	0.00659	0.00659	CcSEcCtD
Verteporfin—Pharyngitis—Rosuvastatin—atherosclerosis	0.00647	0.00647	CcSEcCtD
Verteporfin—Liver function test abnormal—Niacin—atherosclerosis	0.00633	0.00633	CcSEcCtD
Verteporfin—Photosensitivity reaction—Lovastatin—atherosclerosis	0.0063	0.0063	CcSEcCtD
Verteporfin—Liver function test abnormal—Pravastatin—atherosclerosis	0.00623	0.00623	CcSEcCtD
Verteporfin—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00618	0.00618	CcSEcCtD
Verteporfin—Muscular weakness—Niacin—atherosclerosis	0.00605	0.00605	CcSEcCtD
Verteporfin—Muscular weakness—Pravastatin—atherosclerosis	0.00595	0.00595	CcSEcCtD
Verteporfin—Influenza—Niacin—atherosclerosis	0.00593	0.00593	CcSEcCtD
Verteporfin—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00589	0.00589	CcSEcCtD
Verteporfin—Influenza—Pravastatin—atherosclerosis	0.00583	0.00583	CcSEcCtD
Verteporfin—Pharyngitis—Ezetimibe—atherosclerosis	0.00538	0.00538	CcSEcCtD
Verteporfin—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00533	0.00533	CcSEcCtD
Verteporfin—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00513	0.00513	CcSEcCtD
Verteporfin—Flushing—Lovastatin—atherosclerosis	0.00513	0.00513	CcSEcCtD
Verteporfin—Myocardial infarction—Pravastatin—atherosclerosis	0.0051	0.0051	CcSEcCtD
Verteporfin—Sweating—Niacin—atherosclerosis	0.00507	0.00507	CcSEcCtD
Verteporfin—Flushing—Ezetimibe—atherosclerosis	0.00503	0.00503	CcSEcCtD
Verteporfin—Cough—Rosuvastatin—atherosclerosis	0.00495	0.00495	CcSEcCtD
Verteporfin—Angiopathy—Ezetimibe—atherosclerosis	0.00491	0.00491	CcSEcCtD
Verteporfin—Immune system disorder—Ezetimibe—atherosclerosis	0.00489	0.00489	CcSEcCtD
Verteporfin—Arthralgia—Rosuvastatin—atherosclerosis	0.00483	0.00483	CcSEcCtD
Verteporfin—Flushing—Simvastatin—atherosclerosis	0.00479	0.00479	CcSEcCtD
Verteporfin—Haemoglobin—Niacin—atherosclerosis	0.00477	0.00477	CcSEcCtD
Verteporfin—Haemorrhage—Niacin—atherosclerosis	0.00474	0.00474	CcSEcCtD
Verteporfin—Hypoaesthesia—Niacin—atherosclerosis	0.00472	0.00472	CcSEcCtD
Verteporfin—Malnutrition—Ezetimibe—atherosclerosis	0.00472	0.00472	CcSEcCtD
Verteporfin—Back pain—Lovastatin—atherosclerosis	0.00465	0.00465	CcSEcCtD
Verteporfin—Hypoaesthesia—Pravastatin—atherosclerosis	0.00465	0.00465	CcSEcCtD
Verteporfin—Pharyngitis—Pravastatin—atherosclerosis	0.00464	0.00464	CcSEcCtD
Verteporfin—Visual impairment—Niacin—atherosclerosis	0.00457	0.00457	CcSEcCtD
Verteporfin—Back pain—Ezetimibe—atherosclerosis	0.00456	0.00456	CcSEcCtD
Verteporfin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00454	0.00454	CcSEcCtD
Verteporfin—Vision blurred—Lovastatin—atherosclerosis	0.00453	0.00453	CcSEcCtD
Verteporfin—Visual impairment—Pravastatin—atherosclerosis	0.0045	0.0045	CcSEcCtD
Verteporfin—Ill-defined disorder—Lovastatin—atherosclerosis	0.00446	0.00446	CcSEcCtD
Verteporfin—Eye disorder—Niacin—atherosclerosis	0.00443	0.00443	CcSEcCtD
Verteporfin—Flushing—Niacin—atherosclerosis	0.0044	0.0044	CcSEcCtD
Verteporfin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00438	0.00438	CcSEcCtD
Verteporfin—Anaemia—Ezetimibe—atherosclerosis	0.00436	0.00436	CcSEcCtD
Verteporfin—Malaise—Lovastatin—atherosclerosis	0.00434	0.00434	CcSEcCtD
Verteporfin—Cardiac disorder—Pravastatin—atherosclerosis	0.00433	0.00433	CcSEcCtD
Verteporfin—Flushing—Pravastatin—atherosclerosis	0.00433	0.00433	CcSEcCtD
Verteporfin—Vertigo—Lovastatin—atherosclerosis	0.00432	0.00432	CcSEcCtD
Verteporfin—Angiopathy—Niacin—atherosclerosis	0.0043	0.0043	CcSEcCtD
Verteporfin—Malaise—Ezetimibe—atherosclerosis	0.00425	0.00425	CcSEcCtD
Verteporfin—Vision blurred—Simvastatin—atherosclerosis	0.00424	0.00424	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00422	0.00422	CcSEcCtD
Verteporfin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00417	0.00417	CcSEcCtD
Verteporfin—Anaemia—Simvastatin—atherosclerosis	0.00416	0.00416	CcSEcCtD
Verteporfin—Malnutrition—Niacin—atherosclerosis	0.00413	0.00413	CcSEcCtD
Verteporfin—Cough—Ezetimibe—atherosclerosis	0.00411	0.00411	CcSEcCtD
Verteporfin—Chest pain—Lovastatin—atherosclerosis	0.00409	0.00409	CcSEcCtD
Verteporfin—Arthralgia—Lovastatin—atherosclerosis	0.00409	0.00409	CcSEcCtD
Verteporfin—Hypertension—Ezetimibe—atherosclerosis	0.00407	0.00407	CcSEcCtD
Verteporfin—Malaise—Simvastatin—atherosclerosis	0.00406	0.00406	CcSEcCtD
Verteporfin—Discomfort—Lovastatin—atherosclerosis	0.00404	0.00404	CcSEcCtD
Verteporfin—Vertigo—Simvastatin—atherosclerosis	0.00404	0.00404	CcSEcCtD
Verteporfin—Arthralgia—Ezetimibe—atherosclerosis	0.00401	0.00401	CcSEcCtD
Verteporfin—Chest pain—Ezetimibe—atherosclerosis	0.00401	0.00401	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00399	0.00399	CcSEcCtD
Verteporfin—Discomfort—Ezetimibe—atherosclerosis	0.00397	0.00397	CcSEcCtD
Verteporfin—Pain—Rosuvastatin—atherosclerosis	0.00396	0.00396	CcSEcCtD
Verteporfin—Constipation—Rosuvastatin—atherosclerosis	0.00396	0.00396	CcSEcCtD
Verteporfin—Vision blurred—Niacin—atherosclerosis	0.00389	0.00389	CcSEcCtD
Verteporfin—Vision blurred—Pravastatin—atherosclerosis	0.00383	0.00383	CcSEcCtD
Verteporfin—Arthralgia—Simvastatin—atherosclerosis	0.00383	0.00383	CcSEcCtD
Verteporfin—Chest pain—Simvastatin—atherosclerosis	0.00383	0.00383	CcSEcCtD
Verteporfin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00382	0.00382	CcSEcCtD
Verteporfin—Discomfort—Simvastatin—atherosclerosis	0.00378	0.00378	CcSEcCtD
Verteporfin—Nervous system disorder—Ezetimibe—atherosclerosis	0.00377	0.00377	CcSEcCtD
Verteporfin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00377	0.00377	CcSEcCtD
Verteporfin—Anaemia—Pravastatin—atherosclerosis	0.00376	0.00376	CcSEcCtD
Verteporfin—Skin disorder—Ezetimibe—atherosclerosis	0.00374	0.00374	CcSEcCtD
Verteporfin—Vertigo—Niacin—atherosclerosis	0.00371	0.00371	CcSEcCtD
Verteporfin—Syncope—Niacin—atherosclerosis	0.0037	0.0037	CcSEcCtD
Verteporfin—Urticaria—Rosuvastatin—atherosclerosis	0.00368	0.00368	CcSEcCtD
Verteporfin—Oedema—Simvastatin—atherosclerosis	0.00367	0.00367	CcSEcCtD
Verteporfin—Malaise—Pravastatin—atherosclerosis	0.00367	0.00367	CcSEcCtD
Verteporfin—Vertigo—Pravastatin—atherosclerosis	0.00365	0.00365	CcSEcCtD
Verteporfin—Loss of consciousness—Niacin—atherosclerosis	0.00363	0.00363	CcSEcCtD
Verteporfin—Cough—Niacin—atherosclerosis	0.0036	0.0036	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00357	0.00357	CcSEcCtD
Verteporfin—Cough—Pravastatin—atherosclerosis	0.00355	0.00355	CcSEcCtD
Verteporfin—Arthralgia—Niacin—atherosclerosis	0.00352	0.00352	CcSEcCtD
Verteporfin—Hypertension—Pravastatin—atherosclerosis	0.00351	0.00351	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00351	0.00351	CcSEcCtD
Verteporfin—Dyspnoea—Lovastatin—atherosclerosis	0.0035	0.0035	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00349	0.00349	CcSEcCtD
Verteporfin—Arthralgia—Pravastatin—atherosclerosis	0.00346	0.00346	CcSEcCtD
Verteporfin—Chest pain—Pravastatin—atherosclerosis	0.00346	0.00346	CcSEcCtD
Verteporfin—Dyspnoea—Ezetimibe—atherosclerosis	0.00343	0.00343	CcSEcCtD
Verteporfin—Discomfort—Pravastatin—atherosclerosis	0.00342	0.00342	CcSEcCtD
Verteporfin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00341	0.00341	CcSEcCtD
Verteporfin—Oedema—Niacin—atherosclerosis	0.00337	0.00337	CcSEcCtD
Verteporfin—Pain—Lovastatin—atherosclerosis	0.00336	0.00336	CcSEcCtD
Verteporfin—Constipation—Lovastatin—atherosclerosis	0.00336	0.00336	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00334	0.00334	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00332	0.00332	CcSEcCtD
Verteporfin—Asthenia—Rosuvastatin—atherosclerosis	0.00332	0.00332	CcSEcCtD
Verteporfin—Oedema—Pravastatin—atherosclerosis	0.00332	0.00332	CcSEcCtD
Verteporfin—Shock—Niacin—atherosclerosis	0.00332	0.00332	CcSEcCtD
Verteporfin—Pain—Ezetimibe—atherosclerosis	0.00329	0.00329	CcSEcCtD
Verteporfin—Constipation—Ezetimibe—atherosclerosis	0.00329	0.00329	CcSEcCtD
Verteporfin—Pruritus—Rosuvastatin—atherosclerosis	0.00328	0.00328	CcSEcCtD
Verteporfin—Skin disorder—Niacin—atherosclerosis	0.00327	0.00327	CcSEcCtD
Verteporfin—Dyspnoea—Simvastatin—atherosclerosis	0.00327	0.00327	CcSEcCtD
Verteporfin—Hyperhidrosis—Niacin—atherosclerosis	0.00326	0.00326	CcSEcCtD
Verteporfin—Feeling abnormal—Lovastatin—atherosclerosis	0.00323	0.00323	CcSEcCtD
Verteporfin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00321	0.00321	CcSEcCtD
Verteporfin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00317	0.00317	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00317	0.00317	CcSEcCtD
Verteporfin—Pain—Simvastatin—atherosclerosis	0.00314	0.00314	CcSEcCtD
Verteporfin—Constipation—Simvastatin—atherosclerosis	0.00314	0.00314	CcSEcCtD
Verteporfin—Urticaria—Lovastatin—atherosclerosis	0.00312	0.00312	CcSEcCtD
Verteporfin—Body temperature increased—Lovastatin—atherosclerosis	0.0031	0.0031	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00307	0.00307	CcSEcCtD
Verteporfin—Dizziness—Rosuvastatin—atherosclerosis	0.00306	0.00306	CcSEcCtD
Verteporfin—Urticaria—Ezetimibe—atherosclerosis	0.00306	0.00306	CcSEcCtD
Verteporfin—Body temperature increased—Ezetimibe—atherosclerosis	0.00304	0.00304	CcSEcCtD
Verteporfin—Feeling abnormal—Simvastatin—atherosclerosis	0.00302	0.00302	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00302	0.00302	CcSEcCtD
Verteporfin—Dyspnoea—Niacin—atherosclerosis	0.003	0.003	CcSEcCtD
Verteporfin—Dyspnoea—Pravastatin—atherosclerosis	0.00296	0.00296	CcSEcCtD
Verteporfin—Rash—Rosuvastatin—atherosclerosis	0.00292	0.00292	CcSEcCtD
Verteporfin—Dermatitis—Rosuvastatin—atherosclerosis	0.00292	0.00292	CcSEcCtD
Verteporfin—Urticaria—Simvastatin—atherosclerosis	0.00292	0.00292	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Niacin—atherosclerosis	0.00291	0.00291	CcSEcCtD
Verteporfin—Body temperature increased—Simvastatin—atherosclerosis	0.0029	0.0029	CcSEcCtD
Verteporfin—Headache—Rosuvastatin—atherosclerosis	0.0029	0.0029	CcSEcCtD
Verteporfin—Hypersensitivity—Lovastatin—atherosclerosis	0.00289	0.00289	CcSEcCtD
Verteporfin—Pain—Niacin—atherosclerosis	0.00288	0.00288	CcSEcCtD
Verteporfin—Pain—Pravastatin—atherosclerosis	0.00284	0.00284	CcSEcCtD
Verteporfin—Constipation—Pravastatin—atherosclerosis	0.00284	0.00284	CcSEcCtD
Verteporfin—Hypersensitivity—Ezetimibe—atherosclerosis	0.00284	0.00284	CcSEcCtD
Verteporfin—Asthenia—Lovastatin—atherosclerosis	0.00282	0.00282	CcSEcCtD
Verteporfin—Pruritus—Lovastatin—atherosclerosis	0.00278	0.00278	CcSEcCtD
Verteporfin—Asthenia—Ezetimibe—atherosclerosis	0.00276	0.00276	CcSEcCtD
Verteporfin—Nausea—Rosuvastatin—atherosclerosis	0.00275	0.00275	CcSEcCtD
Verteporfin—Feeling abnormal—Pravastatin—atherosclerosis	0.00273	0.00273	CcSEcCtD
Verteporfin—Pruritus—Ezetimibe—atherosclerosis	0.00272	0.00272	CcSEcCtD
Verteporfin—Hypersensitivity—Simvastatin—atherosclerosis	0.0027	0.0027	CcSEcCtD
Verteporfin—Urticaria—Niacin—atherosclerosis	0.00268	0.00268	CcSEcCtD
Verteporfin—Body temperature increased—Niacin—atherosclerosis	0.00266	0.00266	CcSEcCtD
Verteporfin—Urticaria—Pravastatin—atherosclerosis	0.00264	0.00264	CcSEcCtD
Verteporfin—Asthenia—Simvastatin—atherosclerosis	0.00263	0.00263	CcSEcCtD
Verteporfin—Body temperature increased—Pravastatin—atherosclerosis	0.00262	0.00262	CcSEcCtD
Verteporfin—Pruritus—Simvastatin—atherosclerosis	0.0026	0.0026	CcSEcCtD
Verteporfin—Dizziness—Lovastatin—atherosclerosis	0.00259	0.00259	CcSEcCtD
Verteporfin—Dizziness—Ezetimibe—atherosclerosis	0.00254	0.00254	CcSEcCtD
Verteporfin—Hypersensitivity—Niacin—atherosclerosis	0.00248	0.00248	CcSEcCtD
Verteporfin—Rash—Lovastatin—atherosclerosis	0.00247	0.00247	CcSEcCtD
Verteporfin—Dermatitis—Lovastatin—atherosclerosis	0.00247	0.00247	CcSEcCtD
Verteporfin—Headache—Lovastatin—atherosclerosis	0.00246	0.00246	CcSEcCtD
Verteporfin—Hypersensitivity—Pravastatin—atherosclerosis	0.00244	0.00244	CcSEcCtD
Verteporfin—Dizziness—Simvastatin—atherosclerosis	0.00243	0.00243	CcSEcCtD
Verteporfin—Rash—Ezetimibe—atherosclerosis	0.00243	0.00243	CcSEcCtD
Verteporfin—Dermatitis—Ezetimibe—atherosclerosis	0.00242	0.00242	CcSEcCtD
Verteporfin—Asthenia—Niacin—atherosclerosis	0.00242	0.00242	CcSEcCtD
Verteporfin—Headache—Ezetimibe—atherosclerosis	0.00241	0.00241	CcSEcCtD
Verteporfin—Pruritus—Niacin—atherosclerosis	0.00238	0.00238	CcSEcCtD
Verteporfin—Asthenia—Pravastatin—atherosclerosis	0.00238	0.00238	CcSEcCtD
Verteporfin—Pruritus—Pravastatin—atherosclerosis	0.00235	0.00235	CcSEcCtD
Verteporfin—Nausea—Lovastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Verteporfin—Rash—Simvastatin—atherosclerosis	0.00231	0.00231	CcSEcCtD
Verteporfin—Dermatitis—Simvastatin—atherosclerosis	0.00231	0.00231	CcSEcCtD
Verteporfin—Headache—Simvastatin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Verteporfin—Nausea—Ezetimibe—atherosclerosis	0.00229	0.00229	CcSEcCtD
Verteporfin—Dizziness—Niacin—atherosclerosis	0.00223	0.00223	CcSEcCtD
Verteporfin—Dizziness—Pravastatin—atherosclerosis	0.00219	0.00219	CcSEcCtD
Verteporfin—Nausea—Simvastatin—atherosclerosis	0.00218	0.00218	CcSEcCtD
Verteporfin—Rash—Niacin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Verteporfin—Dermatitis—Niacin—atherosclerosis	0.00212	0.00212	CcSEcCtD
Verteporfin—Headache—Niacin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Verteporfin—Rash—Pravastatin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Verteporfin—Dermatitis—Pravastatin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Verteporfin—Headache—Pravastatin—atherosclerosis	0.00208	0.00208	CcSEcCtD
Verteporfin—Nausea—Niacin—atherosclerosis	0.002	0.002	CcSEcCtD
Verteporfin—Nausea—Pravastatin—atherosclerosis	0.00197	0.00197	CcSEcCtD
